TUESDAY, June 7, 2022 (HealthDay News) — A blood take a look at might avoid wasting colon most cancers sufferers from getting pointless chemotherapy following surgical procedure, whereas ensuring that those that would profit from the remedy get it, researchers report.

The circulating tumor DNA (ctDNA) take a look at seems for minute quantities of genetic materials which are launched by cancerous tumors, defined co-researcher Dr. Anne Marie Lennon, director of gastroenterology and hepatology on the Johns Hopkins University School of Medicine, in Baltimore.

The presence of most cancers DNA within the blood is an indication that somebody probably wants follow-up chemotherapy, Lennon stated.

The take a look at practically halved the variety of individuals with stage 2 colon most cancers who bought follow-up chemotherapy after surgical procedure – 15% versus 28% for a management group that obtained commonplace most cancers care, the researchers discovered.

At the identical time, each teams had primarily the identical likelihood of two-year recurrence-free survival, 93% for the blood take a look at group and 92% for the group that bought common care.

“Its backside line was no distinction. This is the primary examine of its type to make use of ctDNA to information affected person remedy,” Lennon stated. “This is the primary examine that has proven you should use circulating tumor DNA to actually personalize most cancers care.”

About 151,000 new colon most cancers instances are anticipated to be identified within the United States in 2022, in accordance with the American Society of Clinical Oncology. An estimated 52,580 deaths will comply with.

For this medical trial, researchers recruited 455 sufferers with operable stage 2 colon most cancers in Australia and New Zealand. At stage 2, colon most cancers has gone by the liner of the bowel however hasn’t unfold into the lymph nodes, Lennon stated.

It’s identified that about 80% of stage 2 colon most cancers sufferers shall be cured solely by surgical elimination of their tumor, whereas 20% can have the most cancers come again except they get follow-up chemo, Lennon stated.

In the examine, two-thirds of sufferers have been randomly assigned to get the ctDNA blood take a look at about 4 weeks after present process surgical procedure. The relaxation had their want for follow-up chemo assessed within the present method, by making a judgment name after wanting over the eliminated most cancers and assessing the way it had unfold within the colon.

Patients with a constructive ctDNA end result who underwent post-surgery chemotherapy wound up with a three-year recurrence-free survival charge of 86%, in accordance with the investigators.

The researchers introduced this examine on Saturday on the annual assembly of the American Society of Clinical Oncology (ASCO), held in Chicago. The outcomes of the medical trial have been additionally revealed within theNew England Journal of Medicine.

This examine probably will change the way in which that stage 2 colon most cancers is handled, stated ASCO Chief Medical Officer Dr. Julie Gralow.

“If I have been a affected person, I’d wish to know what my ctDNA confirmed, for certain,” Gralow stated. “And I do suppose that is actually fairly strong information, so I believe that it has a excessive chance of impacting commonplace of care within the U.S.”

The take a look at would spare many individuals from the debilitating results of chemo, together with nausea, vomiting, fatigue and potential nerve harm, Lennon famous.

At the identical time, it could enhance the possibility that high-risk individuals get chemo even when medical doctors could be in any other case hesitant to have them bear it.

“Often there is a hesitancy to provide older individuals chemotherapy,” Lennon stated. “We’re going to have the ability to say, look, when you’re ctDNA constructive, we all know your threat of recurrence could be very excessive. Even in case you are older, it’s best to take the chemotherapy.”

Gralow and Lennon added that this can be a course of that might be put into place instantly for colon most cancers sufferers wherever within the United States.

While solely main most cancers facilities might carry out such a blood take a look at in-house, there are specialised labs to which the blood might be despatched for a similar evaluation, the researchers added.

“They do excessive quantity and do it extraordinarily effectively, and the price of it has come down dramatically,” Lennon stated. “It’s one thing that everyone ought to be capable to have entry to.”

The subsequent steps shall be to take the ctDNA take a look at and see if it may be utilized to later phases of colon most cancers, in addition to different kinds of most cancers, to assist choose who would possibly profit from chemotherapy, Lennon stated.

More info

The U.S. National Cancer Institute has extra about colon most cancers.

SOURCES: Anne Marie Lennon, MD, PhD, director, gastroenterology and hepatology, Johns Hopkins University School of Medicine, Baltimore; Julie Gralow, MD, chief medical officer, American Society of Clinical Oncology; New England Journal of Medicine, June 4, 2022

The post Gene Test Lets Some Colon Cancer Patients Safely Skip Chemo appeared first on Healthy and Slim Life.

Oct. 20, 21 — “You have colorectal cancer.”

An estimated 150,000 folks hear these phrases or one thing like them within the U.S. annually.

Even earlier than the analysis, the affected person, after having the pleasures of bowel preparation and a colonoscopy, could get up nonetheless groggy from sedation and be instructed, “We’ve found something; I’ll call you in a few days when we get the pathology results.”

You don’t should be a psychiatrist to grasp that instances of nice emotional upheaval, stress, or uncertainty will not be supreme for decision-making, particularly when the one that is requested to resolve is dealing with a problem that will appear overwhelmingly complicated and horrifying.

Many sufferers’ first ideas are to go surfing for data, however that too might be overwhelming. For instance, a Google seek for the phrases “colorectal cancer” turns up roughly 134 million outcomes, in six-tenths of a second, no much less. Those outcomes can vary from the useful and vital, comparable to the web site Cancer.Gov from the U.S. National Cancer Institute, to the silly and downright harmful, comparable to a Facebook web page touting Aunt Tilly’s Miracle Mayonnaise Cure for Colon Cancer. (OK, so we made that final one up, however you get the concept.)

One of probably the most trusted on-line well being web sites is maintained by the Mayo Clinic in Rochester, MN. It gives 11 suggestions for dealing with a most cancers analysis, the primary of which is, “Get the facts about your cancer diagnosis.” That suggestion is the inspiration for the Colorectal Cancer Provider Outreach Program (CRC POP).

Text COLON to 484848

“There are 13,000 gastroenterologists in the country, and we diagnose colorectal cancer 150,000 times a year,” says program creator Brian Dooreck, MD, of Memorial Healthcare System in Pembroke Pines, FL.

“What we created with the Colorectal Cancer Provider Outreach Program is that it now permits gastroenterologists to have a dialog with a affected person — I can say, ‘Now listen, take out your phone, and text the word COLON and send it to 484848,” he says.

Doing so returns a text in a few seconds with the words “You are not alone. You have our support. Here. Now,” and a blue heart emoji, followed by a link that takes the user to a web page with a document containing contact information for the American Cancer Society and other support organizations, including the Colorectal Cancer Alliance, Fight Colorectal Cancer, Colon Cancer Coalition, and Colon Cancer Foundation.

Free resources from the organizations include a helpline staffed 24 hours a day, peer support online or one-to-one support, financial assistance, access to colon cancer screening for under- and uninsured people in select areas, and links to a colorectal cancer patient registry and information.

“I can tell patients, ‘Hey listen, go home, call these groups, get on their websites. I’ll name you in per week, name me should you want me, we’re gonna determine this factor out collectively. This is a good place to get sources, right here and now. It’s a really totally different shift from going residence with out something apart from a therapy plan,” Dooreck says.

No Gain — Except Helping Patients

The text-based service is free.

“There’s no hook, there’s no cost, there’s no sale, it’s not monetized. There’s no gain except helping people,” Dooreck says.

Mark A. Lewis, MD, director of the gastrointestinal most cancers program at Intermountain Healthcare in Murray, UT, himself a survivor of a uncommon most cancers, says this system may help newly identified sufferers minimize by means of the fog that may observe a most cancers analysis.

“I think it’s a great initiative, and it helps unify some of the guidance we give these folks,” he says.

Lewis has the uncommon perspective of seeing the problem from each the oncologist’s and the affected person’s standpoint: Early in his coaching as a hematology-oncology fellow on the Mayo Clinic in 2009, he was identified with the uncommon syndrome a number of endocrine neoplasia sort 1, an inherited situation that causes tumors to develop in hormone-producing glands such because the thyroid or pancreas. He had surgical procedure to take away tumors within the pancreas.

He says the buy-in to CRC POP from main help organizations and from gastroenterologists alike is vital, as a result of most colonoscopies are finished and diagnoses of colorectal most cancers are made in neighborhood settings by docs who could or could not have formal connections with a most cancers heart, fairly than in giant city or suburban networks affiliated with medical faculties.

In most circumstances, he says, the gastroenterologist will make a most cancers analysis and hand the affected person off to a surgeon, who could join with an oncologist and/or radiation oncologist, relying on the affected person’s circumstance. This course of can take weeks, and within the meantime, sufferers are left in limbo.

Offering sufferers a number of reliable sources by means of a easy textual content message is a very interesting a part of the CRC POP initiative, and it will possibly assist sufferers really feel they’re extra in charge of their care, Lewis says.

Multidisciplinary Care

The connection to sources provided by this system are solely a part of the package deal of providers that sufferers obtain at giant tutorial medical facilities.

“Our approach to a newly diagnosed patient happens in the context of a multidisciplinary visit,” says Caroline Kuhlman, a nurse practitioner at Mass General Cancer Center in Boston.

Patients meet with a surgeon, oncologist, and generally radiation oncologist, she says. They are additionally given written data and might entry a affected person useful resource heart.

Patients will also be referred as wanted to different sources within the hospital system, together with nutritionists, social employees who may help them discover out extra about social and monetary help, and academic sources comparable to data periods on what to anticipate if they are going to be getting chemotherapy.

“We have homegrown support services that we make available to patients if they either ask for them or if we ascertain that those services would be important components of their care,” Kuhlman says.

Similarly, at Intermountain Healthcare, sufferers newly identified with most cancers are contacted inside 24 hours by affected person navigators who assist them handle considerations and expectations about their care and join them to sources each within the hospital and the neighborhood.

Although their practices differ in measurement and scope, Dooreck, Lewis, and Kuhlman all agree with the central message and goal of CRC POP: “You are not alone. You have our support.”

The post Need Help With a Colon Cancer Diagnosis? Text COLON to 484848 appeared first on Healthy and Slim Life.